Research centre

Last updated on: 25/06/2014

1. Contact details{View data sources/studies associated with this centre}

Name of organisation

1) Department/Research groupServicio de Epidemiología, Prevención y Promoción de la Salud

2) Organisation/affiliationInstituto de Salud Pública de Navarra

Short Name in the inventoryISP Navarra

Website/Homepagehttp://www.isp.navarra.es

Administrative Contact

Title Dr

Last name Castilla

First name Jesús

Address line 1Leyre 15

Address line 2

Address line 3

CityPamplona

Postcode31003

CountrySpain

Phone number (incl. country code)34-848421477

Alternative phone number

Fax number (incl. country code)34-848423474

Email address jcastilc@navarra.es

Scientific Contact

Title Dr

Last name Castilla

First name Jesús

Address line 1Leyre 15

Address line 2

Address line 3

CityPamplona

Postcode31003

CountrySpain

Phone number (incl. country code)34-848421477

Alternative phone number

Fax number (incl. country code)34-848423474

Email address jcastilc@navarra.es

2. Description

Public Health Institute of Navarre, Spain (ISPN) This is regional institute depending on the Health Department of the Navarre Government. It has the aim of public health protection for all the population in the region. It has the following areas: public health laboratory, alimentary security, environmental health protection, Chronic diseases epidemiology, Infectious diseases control and immunization, population-based programmes for cancer screening and health promotion The area of infectious diseases and immunization develops the following activities: Regional immunization programmes. Active epidemiological and microbiological surveillance. The ISPN has research lines in public health of chronic diseases (Cancer Register Network, EPIC, InterAct, Epic-Heart, etc.) and vaccine preventable diseases (I-MOVE, Rotavirus network, varicella, IPD, etc.). The ISPN participate in the CIBERESP (Spanish Network of Research in Epidemiology and Public Health).

3. Category

Government based

4. Available resources

In houseVia Contacts/Network

Epidemiologist/Pharmacoepidemiologist Yes No

Statistician Yes No

Clinician Yes No

Pharmacist No Yes

Ethics expertise No Yes

Legal expertise No Yes

Regulatory expertise No Yes

Microbiologist/virologist No Yes

Expert in vaccines Yes No

14. Interest in research opportunities which are funded

By government

By research councils

By EU funding schemes

15. Interest in contract research only if free to publish results

16. Selected publications of the last 5 calendar years

ReferenceLink to web-publication

Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Morán J, Irisarri F, Arriazu M, Albéniz E, Ezpeleta C, Barricarte A; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill. 2013 Jan 31;18(5).doi:pii: 20388

Castilla J, Beristain X, Martínez Artola V, Navascués A, García Cenoz M, Álvarez N, Polo I, Mazón A, Gil-Setas A, Barricarte A. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine 2012;30(3):539-43.

Castilla J, Godoy P, Domínguez A, Martínez-Baz I, Astray J, Martín V, Delgado-Rodríguez M, Baricot M, Soldevila N, Mayoral JM, Quintana JM, Galán JC, Castro A, González-Candelas F, Garín O, Saez M, Tamames S, Pumarola T; CIBERESP Cases and Controls in Influenza Working Group Spain. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013 Jul;57(2):167-75.doi:10.1093/cid/cit194

Guevara M, Ezpeleta C, Gil-Setas A, Torroba L, Beristain X, Aguinaga A, García-Irure JJ, Navascués A, García-Cenoz M, Castilla J; Working Group for Surveillance of the Pneumococcal Disease in Navarre. Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013. Vaccine. 2014 May 7;32(22):2553-62doi: 10.1016/j.vaccine.2014.03.054.

García Cenoz M, Castilla J, Chamorro J, Martínez-Baz I, Martínez-Artola V, Irisarri F, Arriazu M, Ezpeleta C, Barricarte A. Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012. Euro Surveill. 2013 Aug 8;18(32):20552. PubMed PMID: 23968827.

Top